Sarah James Hill, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
BRCA1 Protein | 5 | 2023 | 1149 | 0.890 |
Why?
|
DNA Breaks, Double-Stranded | 4 | 2016 | 594 | 0.590 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 450 | 0.570 |
Why?
|
RNA-Binding Protein FUS | 1 | 2016 | 72 | 0.550 |
Why?
|
DNA Repair | 4 | 2015 | 2046 | 0.380 |
Why?
|
Ovarian Neoplasms | 3 | 2024 | 4838 | 0.370 |
Why?
|
DNA Damage | 3 | 2015 | 2432 | 0.310 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2016 | 1414 | 0.270 |
Why?
|
Transcription, Genetic | 3 | 2016 | 7722 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8428 | 0.250 |
Why?
|
Peptide Library | 1 | 2022 | 349 | 0.200 |
Why?
|
DNA-Binding Proteins | 2 | 2016 | 9648 | 0.180 |
Why?
|
Genital Neoplasms, Female | 1 | 2024 | 523 | 0.160 |
Why?
|
BRCA2 Protein | 1 | 2023 | 794 | 0.160 |
Why?
|
Ultraviolet Rays | 2 | 2014 | 1060 | 0.160 |
Why?
|
Methyl Methanesulfonate | 1 | 2014 | 27 | 0.130 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1038 | 0.130 |
Why?
|
Neoplasms, Basal Cell | 1 | 2014 | 31 | 0.120 |
Why?
|
RNA Helicases | 1 | 2015 | 142 | 0.120 |
Why?
|
Endometrial Neoplasms | 1 | 2023 | 1353 | 0.120 |
Why?
|
Mutagens | 1 | 2014 | 168 | 0.120 |
Why?
|
Inhibitory Concentration 50 | 1 | 2014 | 459 | 0.110 |
Why?
|
HeLa Cells | 3 | 2015 | 3128 | 0.110 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 6314 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3557 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2133 | 0.100 |
Why?
|
Motor Neurons | 1 | 2016 | 844 | 0.100 |
Why?
|
Protein Transport | 1 | 2016 | 1988 | 0.090 |
Why?
|
Cell Line, Tumor | 3 | 2022 | 16689 | 0.090 |
Why?
|
Protein Interaction Mapping | 1 | 2014 | 627 | 0.090 |
Why?
|
DNA Replication | 2 | 2014 | 1399 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4479 | 0.070 |
Why?
|
Survival Rate | 1 | 2020 | 12788 | 0.070 |
Why?
|
NF-kappa B | 1 | 2014 | 2499 | 0.070 |
Why?
|
Cell Proliferation | 1 | 2020 | 10481 | 0.060 |
Why?
|
Cell Line | 2 | 2016 | 15997 | 0.060 |
Why?
|
Models, Genetic | 1 | 2015 | 3494 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9727 | 0.060 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 2024 | 139 | 0.060 |
Why?
|
Protein Binding | 1 | 2014 | 9386 | 0.050 |
Why?
|
CA-125 Antigen | 1 | 2024 | 286 | 0.050 |
Why?
|
Histones | 1 | 2011 | 2599 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2011 | 3023 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 631 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2011 | 4554 | 0.040 |
Why?
|
Humans | 10 | 2024 | 744343 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 3870 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5853 | 0.030 |
Why?
|
Female | 5 | 2024 | 380194 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2022 | 1988 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2460 | 0.030 |
Why?
|
Mice | 1 | 2020 | 81183 | 0.030 |
Why?
|
Replication Protein C | 1 | 2011 | 19 | 0.030 |
Why?
|
DNA Helicases | 1 | 2015 | 859 | 0.020 |
Why?
|
Animals | 1 | 2020 | 168757 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 893 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 20822 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2505 | 0.020 |
Why?
|
Ubiquitination | 1 | 2011 | 1012 | 0.020 |
Why?
|
Blotting, Western | 1 | 2011 | 5179 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2967 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3505 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2011 | 1861 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 2849 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8436 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2011 | 3462 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 72290 | 0.010 |
Why?
|
Signal Transduction | 1 | 2011 | 23403 | 0.000 |
Why?
|